Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2022 | Challenges of treating young adult cancer patients

Vanessa McLelland • 4 Oct 2022
BOPA 2022
General

Vanessa McLelland, MPharm, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol, UK, discusses the challenges of treating young adult patients with cancer, including the difficulty of running clinical trials with low patient numbers. This interview took place at the British Oncology Pharmacy Association (BOPA) 2022 Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vanessa McLelland

1:19
Optimizing treatment protocols for young adult patients with cancer
Vanessa McLelland • 9 Oct 2023
0:50
Considerations for researching pharmacological management of pediatric cancer
Vanessa McLelland • 4 Oct 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals